MSLE · Satellos Bioscience Inc
United States · RS rating 20 · As of 2026-11-03
| Price | 6.37 USD |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 20 / 20 / 16 / 49 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 19 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -5.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +51.0% |
| Market cap (USD) | $141.9M |